200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Risk Factors
Jaguar Health Enters $3.4M Exchange Agreement with Streeterville Capital
Jaguar Health Enters Exchange Agreement for $1.68M Note Reduction
Jaguar Health Enters Exchange Agreements; Issues 547,898 Shares to Streeterville
Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Other Events
Jaguar Health Enters Exchange Agreement with LAS for $175,016.36
Announces Reverse Stock Split
Other Events
Q2
Notice of Late Filing for Quarterly Report
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Definitive Proxy Statement
PRER14A
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload